Accelerating Innovation at Leica Biosystems

Broadest Offering Across Bioprocessing Workflow Cell culture & SUT Chromatography E Media Bags & Mixers Bioreactor Depth Filter Resins Chromatography Columns Polishing Column Devices Equipment cytiva PALL cytiva ~$7.5B DHR BIOPROCESSING REVENUE 2021E Filtration Drug Product Filtration Skids & Consumables Concentration & Sterile Filtration HIGHEST IMPACT & MAXIMUM VALUE TO CUSTOMERS: FOCUSED ON AREAS OF ↑ Facility efficiency Manufacturing flexibility ↑ Development partnership Speed to market PALL ↓ Processing time ↓ Operating costs ✓ Footprint ✓ Capital spending Aseptic Filling cytiva Complementary offerings establish a leading position DANAHER

View entire presentation